Search results for: 'revenue reimbursement'

Healthcare challenges such as workforce shortages, decline in revenue and operating margins, patient payment collection issues, complex claims compliance requirements, and increased patient expectations for seamless experience are compelling healthcare providers to rethink their revenue cycle management (RCM) approach. Providers are realizing the i...

The revenue cycle management (RCM) operations space is at a structural inflection, and the convergence of technology, regulations, and dynamic buyer expectations is compelling RCM vendors to act and upgrade their value propositions and strategies to remain competitive. Providers have been under significant financial stress in the past few years. Ho...

20 Mar 2019  |  North America  |  Market Research

Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

Infographics

×

Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...

This research service provides an analysis of the procedure volumes and reimbursement trends for heart and lung imaging using magnetic resonance imaging (MRI). Growth opportunities in terms of clinical applications and technologies are provided as well as an overview of unit shipment and revenue forecasts at the global level from 2019 to 2026. Reim...

This research highlights the various issues affecting the pricing and reimbursement environment for generics in Europe. It includes an overview of the generics market, key trends, country-wise market trends, list of market participants, strategic suggestions and decision support databases.

An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing at 3% to 4% every year. While the COVID-19 pandemic in 2020 led to a drop in CT procedures by over 20%, the industry is expected to be completely functional by the end of 2021. Pandemic-based sanitization protocols and patient hesitancy remain restrain...

This study provides a roadmap for understanding the hospital revenue management (RCM) market. Herein Frost & Sullivan provides an in-depth overview of the market including major government initiatives driving changes in the market, defines and describes major market segments including technology solutions and services used by hospitals, discusses t...

Frost & Sullivan estimates the aging population and accompanying retirements to cause a significant physician shortfall of 55,000 to 150,000 by 2030, creating a gap in the healthcare system. Expanding the role of autonomous robots can mitigate the shortage. The healthcare sector is forecast to expand rapidly with the decentralization of institu...

10 May 2018  |  North America  |  Market Research

Global Tissue Diagnostics Market, Forecast to 2022

Liquid Biopsy for Therapy Monitoring and Reimbursement Cuts Impede Long-term Prospects of Tissue Diagnostics Market

Infographics

×

Key Issues Addressed

Tissue diagnostic techniques are used to recognize specific antigens in preserved tissues. The process includes slicing thin tissue samples that are treated with a hematoxylin and eosin (H&E) stain, and then are formalin-fixed paraffin-embedded (FFPE) to diagnose tumors and other histopathology specimens. This has traditionally required skilled pat...